Terms: = Colorectal cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
15 results:
1. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-ctla-4 therapy through induction of intratumoral regulatory T cells.
Liu Z; Zheng N; Li J; Li C; Zheng D; Jiang X; Ge X; Liu M; Liu L; Song Z; Bao L; Zhan Y; Gao X
Drug Resist Updat; 2022 Dec; 65():100886. PubMed ID: 36370665
[TBL] [Abstract] [Full Text] [Related]
2. Identification and functional analysis of lncRNAs and mRNAs between tumorigenesis and metastasis in CRC.
Liu H; Tian Y; Li J; Zhang G; Liu Q; Yang M; Yue L; Cao Q; Zhang G; Cheng Y; Kong N; Fang L; Li S; Sun Q
Aging (Albany NY); 2021 Dec; 13(24):25859-25885. PubMed ID: 34954693
[TBL] [Abstract] [Full Text] [Related]
3. Immune checkpoints and liver resection after neoadjuvant chemotherapy including bevacizumab in patients with microsatellite-stable colorectal liver metastases.
Stift J; Graf A; Neudert B; Herac M; Woeran K; Tamandl D; Laengle J; Schwarz C; Wrba F; Kaczirek K; Stremitzer S
HPB (Oxford); 2022 Jan; 24(1):40-46. PubMed ID: 34158230
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma.
Wang X; Cao K; Guo E; Mao X; Guo L; Zhang C; Guo J; Wang G; Yang X; Sun J; Miao S
Front Immunol; 2021; 12():658631. PubMed ID: 33995377
[TBL] [Abstract] [Full Text] [Related]
5. Aortic calcification is associated with non-infective rather than infective postoperative complications following colorectal cancer resection: an observational cohort study.
Knight KA; Fei CH; Boland KF; Dolan DR; Golder AM; McMillan DC; Horgan PG; Black DH; Park JH; Roxburgh CSD
Eur Radiol; 2021 Jun; 31(6):4319-4329. PubMed ID: 33201280
[TBL] [Abstract] [Full Text] [Related]
6. Microsatellite instability status differentially associates with intratumoral immune microenvironment in human cancers.
Zhang P; Liu M; Cui Y; Zheng P; Liu Y
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32823273
[TBL] [Abstract] [Full Text] [Related]
7. The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic cancers.
Kooshkaki O; Derakhshani A; Safarpour H; Najafi S; Vahedi P; Brunetti O; Torabi M; Lotfinejad P; Paradiso AV; Racanelli V; Silvestris N; Baradaran B
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708748
[TBL] [Abstract] [Full Text] [Related]
8. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
Kitsou M; Ayiomamitis GD; Zaravinos A
Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
[TBL] [Abstract] [Full Text] [Related]
9. The association between clinical outcome and CD8
Kleist B; Bagdonas M; Oommen P; Schoenhardt I; Levermann J; Poetsch M
Histopathology; 2018 Jan; 72(2):201-215. PubMed ID: 28746988
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer.
Kimura Y; Morohashi S; Yoshizawa T; Suzuki T; Morohashi H; Sakamoto Y; Koyama M; Murata A; Kijima H; Hakamada K
Mol Med Rep; 2016 Feb; 13(2):1551-7. PubMed ID: 26676225
[TBL] [Abstract] [Full Text] [Related]
11. The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon.
Grimm WA; Messer JS; Murphy SF; Nero T; Lodolce JP; Weber CR; Logsdon MF; Bartulis S; Sylvester BE; Springer A; Dougherty U; Niewold TB; Kupfer SS; Ellis N; Huo D; Bissonnette M; Boone DL
Gut; 2016 Mar; 65(3):456-64. PubMed ID: 25645662
[TBL] [Abstract] [Full Text] [Related]
12. Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease.
Navaneethan U; G K Venkatesh P; Lashner BA; Lopez R; Kiran RP; Shen B
J Crohns Colitis; 2012 Jul; 6(6):674-80. PubMed ID: 22398102
[TBL] [Abstract] [Full Text] [Related]
13. [Association of microvessel density and blood vessel invasion with the prognosis in rectal carcinoma at stages I to II].
Zhou YJ; Ye Q; Lu HS; Yang YH; Guan GX; Huang CM; Wang C; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jul; 13(7):516-9. PubMed ID: 20658366
[TBL] [Abstract] [Full Text] [Related]
14. [Evaluation of chemosensitivity testing by CD-DST, and TS and DPD activity in cases of colorectal liver].
Tono T; Takahashi H; Kanoh T; Nakano Y; Tamagaki S; Yasue A; Okada K; Matsui S; Iwazawa T; Yano H; Kinuta M; Okamura J; Monden T
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1523-6. PubMed ID: 11707970
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
[TBL] [Abstract] [Full Text] [Related]
